AJH-2947 safety study in healthy men
Part of Brain & nervous system, Pain clinical trials.
This trial tests the safety of a new oral drug, AJH-2947, in healthy Korean or Caucasian men. It helps determine how the body processes the drug and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male of Korean or Caucasian descent, aged 19 to 55.
- You weigh between 110 and 198 pounds (50 to 90 kg) and have a body mass index (BMI) between 18.5 and 30.
- You agree to stay in the clinic for the study and use sunscreen until the study ends.
- You have no major medical conditions like heart, liver, kidney, or stomach problems, and no history of drug allergies or abuse.
- You can avoid caffeine, alcohol, smoking, grapefruit, and other medications during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This trial is testing a new drug called HX15001 in healthy adults to see how safe it is and how the body processes it. It may help researchers decide if the drug can be tested in people with a specific condition in the future.
This is an early-stage safety test of a new drug called JW0061 in people without serious health conditions. Researchers will monitor how your body processes the drug and any side effects that occur.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Hear when a new Chronic Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.